baber/WOPTO huggingface dataset:
Patent AU-755684-B2 (AU)
Title: Crash attenuation system
Inventor: REID JOHN D
IPC: F16F7/12
Filed: 2000-01-11
Granted: 2002-12-19
Abstract: A crash attenuation system having an impact head, and energy absorption mechanism. The energy absorbing mechanism has a mandrel for rupturing thin-walled tubes in a controlled rupture to absorb impact forces from a colliding vehicle. A frame may be used to mount the system to a truck, trailer, guardrail, median barrier end treatment, or a crash cushion. Stress concentrators may be incorporated into the tubes and the mandrels to selectively control rupturing and energy dissipation.
Patent AU-693219-B2 (AU)
Title: Amino acid-derived diaminopropanols
Inventor: PAL BIMAN
IPC: C07D207/09
Filed: 1995-07-05
Granted: 1998-06-25
Abstract: The present invention relates to a method of forming a 1,3-diamino-3-substituted-2-propanol chemical intermediate from which various chemicals, such as selected protease-inhibitors and other drugs, as well as polymers, can be synthesized. The method includes contacting a nitromethyl amino acid compound with at least one reducing agent to form the 1,3-diamino-3-substituted-2-propanol chemical intermediate.
Patent AU-772428-B2 (AU)
Title: Monocarboxylic acid based antifreeze composition for diesel engines
Inventor: TURCOTTE DAVID E
IPC: C09K5/20
Filed: 2000-02-25
Granted: 2004-04-29
Abstract: The present invention relates to an acid based antifreeze coolant formulatio n for heavy duty applications such as for diesel engines which may be used for inhibition and prevention erosion and corrosion of aluminum and the corrosio n of other metals exposed to an aqueous liquid in automotive coolant systems. The formulation further inhibits mineral scale. It may be packaged as an ethylene glycol based additive for use in new engines or in a concentrated inhibition package as an additive as for reinhibition of used coolant. The combination of a mixture of ethylene or propylene glycol, a monobasic aliphatic organic acid, azoles, low levels of molybdates, a combination of nitrite and/or nitrate salts, polyvinylpyrrolidone, a hydroxide salt, silicates and/or siloxane stabilized silicates with transition metal compoun ds provide a synergistic protective effect against the cavitation corrosion of aluminum in aqueous liquids reducing the corrosion rate and is effective at relatively low concentrations and varying pH ranges.
Patent AU-553858-B2 (AU)
Title: Nonionic detergents containing magnesium sulphate
Inventor: LAMBERTI VINCENT
IPC: C11D1/66
Filed: 1984-11-23
Granted: 1986-07-31
Abstract: @ The bleeding out during product storage of nonionic detergent active compounds from powdered detergent compositions containing such surfactants is effectively arrested and retarded with the use of magnesium sulphate heptahydrate as a uniformly distributed and intimately mixed ingredient of such detergent compositions.Advantageously, the magnesium sulphate is mixed with the nonionic detergent-active compound in anhydrous form and hydrated to its heptahydrate form thereafter. A mixture of magnesium sulphate heptahydrate together with polyvinyl alcohol when uniformly distributed within a detergent composition is also effective in arresting and retarding nonionic bleeding.
Patent AU-616017-B2 (AU)
Title: Process for the conversion of a hydrocarbonaceous feedstock
Inventor: MINDERHOUD JOHANNES KORNELIS
IPC: B01J29/40
Filed: 1989-06-14
Granted: 1991-10-17
Abstract: Process for the conversion of a hydrocarbonaceous feedstock containing hydrocarbons having such a boiling range that an amount thereof boils at a temperature of at least 330  DEG C, which process comprises contacting the feedstock with a zeolitic catalyst comprising a zeolite with a pore diameter of 0.3 to 0.7 nm at a temperature of at most 480 DEG C and during less than 10 seconds.
Patent AU-561377-B2 (AU)
Title: Frequency stabilized ballast system
Inventor: HANLET JACQUES M
IPC: H05B41/282
Filed: 1985-01-08
Granted: 1987-05-07
Abstract: A frequency stabilized automatic gain controlled ballast system (10) which is coupled to a power source (12) in order to operate at least one of a pair of gas discharge tubes (40 and 40'). Each of the gas discharge tubes (40, 40') include respective filaments (42, 44 and 42', 44'). A frequency control circuit (11) is coupled to the power source (12) and includes a frequency control transformer (43) and a frequency control capacitor (50) for establishing a constant oscillation signal at a predetermined frequency. A switching network (13) is connected to the frequency control circuit (11) for establishing a pulsating current responsive to the constant oscillation signal of predetermined frequency. Induction circuitry (15) is coupled to the switching network (13) and the frequency control circuit (11) and includes an inverter transformer (78) as well as coupling capacitors (86 and 88) for generating a voltage across the gas discharge tubes (40 and 40'). Automatic gain control circuitry (17) is included in inverter transformer (78) and is made up of a pair of secondary windings (80 and 81) wound in a manner to provide a negative feedback voltage to each of the transistors (70 and 70') of switching network (13). The inverter transformer (78) has a pair of primary windings (82 and 84) which operate alternately and are coupled to the primary winding (45) of frequency control transformer (43) to provide a repetitive cycle. First and second coupling capacitors (86 and 88) are coupled to primary windings (82 and 84) of inverter transformer (78) and filaments (42 and 42') of gas discharge tubes (40 and 40') for discharging the induced voltage across the tubes (40 and 40').
Patent AU-699183-B2 (AU)
Title: Laminin chains: diagnostic and therapeutic use
Inventor: TRYGGVASON KARL
IPC: C12Q1/6886
Filed: 1995-10-04
Granted: 1998-11-26
Abstract: The instant invention provides for the identification, diagnosis, monitoring, and treatment of invasive cells using the laminin 5 gamma-2 chain protein or nucleic acid sequence, or antibodies thereto.
Patent AU-657855-B2 (AU)
Title: Office chair
Inventor: DESANTA SIMON
IPC: A47C1/032
Filed: 1993-03-18
Granted: 1995-03-23
Abstract: PCT No. PCT/EP93/00644 Sec. 371 Date Jan. 19, 1994 Sec. 102(e) Date Jan. 19, 1994 PCT Filed Mar. 18, 1993 PCT Pub. No. WO93/18687 PCT Pub. Date Sep. 30, 1993.An office chair comprises a column projecting from a pedestal, a seat, a back rest and a bracket projecting from the upper end of the column forwards. The seat is supported by the front end of the bracket in a first transverse pivot axis. A support member is supported in the central portion of the bracket by a second transverse pivot axis and extends below the seat up to the back rest which is carried by the support member. The support member is resiliently supported by the column and/or the bracket. The rear end portion of the seat is shiftably supported by the support member.
Patent AU-572949-B2 (AU)
Title: Bis (disubstituted-phosphino) derivatives
Inventor: HILL DAVID TAYLOR
IPC: C07F9/50
Filed: 1985-01-29
Granted: 1988-05-19
Abstract: Pharmaceutical compositions and compounds for treating tumors by administering an effective tumor cell growth-inhibiting amount of a [ alpha ,  omega -bis (disubstituted phosphino)hydrocarbon] digold(I), digold(III), disilver(I) or dicopper(I) derivative to an animal afflicted by such tumor cells, are described.
Patent AU-622920-B2 (AU)
Title: Hydrophilic colloid compositions for photographic materials
Inventor: PITT ALAN ROBERT
IPC: G03C1/38
Filed: 1989-07-25
Granted: 1992-04-30
Abstract: Hydrophilic colloid compositions suitable for use in the preparation of photographic silver halide materials comprise a surface active agent having the formula <CHEM>  wherein each of R1, R2 and R3 independently is a substituted or unsubstituted alkyl group or a substituted or unsubstituted aryl group;  each of X and Y is -H or -Q<->M<+>;  Q<-> is an anion; and,  M<+> is a cation; provided that when X is -H, Y is -Q<->M<+> and that when X is -Q<->M<+>, Y is -H. The surface active agent may be employed as a coating aid or as a dispersing aid.
Patent AU-570300-B2 (AU)
Title: Multi-stage reactor for moving catalyst bed
Inventor: GREENWOOD ARTHUR RAYMOND
IPC: B01J8/12
Filed: 1985-02-21
Granted: 1988-03-10
Abstract: There is disclosed an improved multiple-stage reactor system for effecting radial flow contact of a reactant stream (fed in at 5 and 39) with catalyst particles (fed in at 6) movable as an annular bed (in sections 15 and 33) through said system by gravity flow. The improved multiple stage reactor system may be advantageously employed in the catalytic conversion of hydrocarbons and in particular in the catalytic reforming of a naphtha boiling range charge stock.
Patent AU-578393-B2 (AU)
Title: Transmission of messages in the form of data packets
Inventor: BOURGONJE WOUTER
IPC: H04M9/02
Filed: 1985-07-26
Granted: 1988-10-20
Abstract: A method of transmitting data packets in a message-switched channel (signalling channel) of a time-division multiplex system with CSMA-CD. Interference-free transmission in the message-switched channel ensures the absence of collisions on occupying the circuit-switched connection. Message mutilation and collision on accessing the message-switched channel are remedied by a retransmission procedure in which the unique station address number determines the frame number in which the retransmission may start. This procedure guarantees that a station accesses the message-switched channel within a very short period of time. This guaranteed access is not possible with the prior art CSMA-CD buses.
Patent AU-581458-B2 (AU)
Title: Closed hemapheresis system and method
Inventor: MCLAUGHLIN WILLIAM FRANCIS
IPC: B01D43/00
Filed: 1985-08-19
Granted: 1989-02-23
Abstract: A centrifugal separator system is provided for extracting lighter matter from a liquid suspension. The separator includes a housing having an axis, an inlet port, a lighter matter outlet port and a heavier matter outlet port spaced from the inlet port. A rotatable interior double shell rotor is disposed within the housing. The rotor includes outer and inner shells and defines a centrifugation gap therebetween. The rotor is spaced from the housing by a flow gap. The outer shell includes means providing communication between the centrifugation gap, the inlet port and the heavier outlet port. Means are provided in the double shell rotor for conducting lighter matter from the centrifugation gap to the lighter matter outlet port.
Patent AU-582391-B2 (AU)
Title: Prevulcanized treads and method and apparatus for their production
Inventor: REMOND MICHEL
IPC: B29C43/22
Filed: 1985-10-04
Granted: 1989-03-23
Abstract: 1. Claims for designated states : DE, GB, IT, NL only (set A) A prevulcanized tread having, in stress-free condition, a constant curvature in its longitudinal direction whose radius corresponds substantially to that of tires to be recapped, the sole of the tread being concave, characterized by the fact that the tread has two ends in its longitudinal direction, and by the fact that the tread automatically inscribes itself between two parallel planes spaced apart by the width of the tread. 1. Claims for designated states : AT, BE, CH, FR, LI, LU, SE only (set B) A prevulcanized tread having, in stress-free condition, a constant curvature in its longitudinal direction whose radius corresponds substantially to that of tires to be recapped, the sole of the tread being concave, characterized by the fact that tha tread has two ends in its longitudinal direction.
Patent AU-762317-B2 (AU)
Title: Bechamel-type sauce
Inventor: BRONGNIART LAURENCE
IPC: A23L23/00
Filed: 1999-09-20
Granted: 2003-06-19
Abstract: Bechamel-type sauce undergoes a less than 10% change in viscosity (measured at a shear rate of 10 sec<-1>) when subjected to two different shearing treatments and/or before and after one or more freeze-thaw cycles.
Patent AU-692376-B2 (AU)
Title: Ovulation-inhibiting means for hormonal contraception
Inventor: EHRLICH MARIKA DR MED
IPC: A61K38/35
Filed: 1996-04-09
Granted: 1998-06-04
Abstract: An ovulation-inhibiting preparation for hormonal contraception, comprising two hormone constituents packed spatially separate in a packing unit intended for chronological, sequential oral administration, said constituents each comprising a plurality of daily hormone units accommodated spatially separate and individually removable in the packaging unit. The first hormone constituent consists essentially of an estrogen preparation which effects a disturbance of the follicle stimulation; the second hormone constituent consists of an estrogen preparation and a gestagen preparation in a dose at least adequate for inhibiting ovulation. The total number of daily hormone units is equal to the total number of days in the desired cycle, and the number of daily units of the first hormone constituent is less than the number of daily units of the second hormone constituent. The first hormone constituent comprises 5 to 14 daily units, and the second hormone constituent comprises 23 to 14 daily units.
Patent AU-656514-B2 (AU)
Title: Detection of a nucleic acid sequence or a change therein
Inventor: DALE JAMES LANGHAM
IPC: C12Q1/6813
Filed: 1990-02-13
Granted: 1995-02-09
Abstract: A method for detecting a specific polynucleotide sequence in a material is disclosed. The method includes exposing said material to an oligonucleotide primer having a sequence complementary to part of said specific polynucleotide sequence wherein said primer binds to part of said polynucleotide sequence when present in said material. Primer bound to the polynucleotide sequence is extended wherein any extended primer includes a detectable element and/or a separation element. Any extended primer is then separated into a fraction wherein said fraction does not have detectable element not included in said extended primer. One then determines whether any extended primer is present in said fraction by assaying said fraction for said extended primer wherein the presence of said extended primer is indicative of the presence of the specific polynucleotide sequence in said material and the absence of said extended primer in said fraction is indicative of the absence of the specific polynucleotide sequence in said material.
Patent AU-755710-B2 (AU)
Title: Conjugates of DNA interacting groups with steroid hormones for use as nucleic acid transfection agents
Inventor: FREY FELIX
IPC: C12N15/87
Filed: 1999-08-19
Granted: 2002-12-19
Abstract: The present invention relates to novel compounds comprising a steroid hormone linked to a DNA-interacting molecule that target nucleic acids to the cell nucleus. Further, the invention relates to a method for introducing nucleic acids into the nucleus of cells with the help of such compounds. Pharmaceutical preparations containing such compounds and the use of such compounds for gene therapy are also provided.
Patent AU-642865-B2 (AU)
Title: Disease-resistant transgenic plants
Inventor: RYALS JOHN A
IPC: C12N15/82
Filed: 1990-03-23
Granted: 1993-11-04
Abstract: The present invention relates to chimeric DNA constructs useful for producing transgenic disease-resistant plants and to genetic engineering of plants to produce the phenotype of disease resistance. In particular it relates to constitutive expression in transgenic plants of DNA sequences which encode pathogenesis-related proteins (PRPs) A further objective of the present invention are transgenic plants constitutively expressing induced levels of plant PRPs or substantially homologous proteins, providing an enhanced disease-resistant phenotype with respect to wild-type plants. Another object of the present invention is to provide transgenic plants constitutively transcribing sense or antisense mRNA strands of DNA sequences encoding plant PRPs or transcribing sense or antisense mRNA strands of DNA sequences substantially homologous to genomic or cDNA sequences encoding plant PRPs, such transgenic plants thus having an enhanced disease-resistant phenotype with respect to wild-type plants.
Patent AU-776715-B2 (AU)
Title: Combinations for introducing nucleic acids into cells
Inventor: PLANK CHRISTIAN
IPC: C08G65/329
Filed: 2000-06-21
Granted: 2004-09-16
Abstract: Combinations of a carrier and a complex consisting of a nucleic acid molecule and a copolymer are described, wherein the copolymer consists of an amphiphilic polymer, preferably polyethylene glycol, and a charged effector molecule, in particular a peptide or peptide derivative, as well as their use for the transfer of nucleic acid molecules into cells.
Patent AU-690085-B2 (AU)
Title: Heat shock proteins and the treatment of tumours
Inventor: COLSTON MICHAEL JOSEPH
IPC: A61K39/00
Filed: 1993-11-15
Granted: 1998-04-23
Abstract: An expression vector is provided for use in the treatment of neoplasms which vector comprises nucleic acid including at least one which encodes in expressible form a polypeptide which is a heat shock polypeptide (hsp) or a chaperone.
Patent AU-671328-B2 (AU)
Title: Abrasive attachment system for rotative abrading applications
Inventor: JANTSCHEK ROBERT JOSEPH
IPC: B24D11/00
Filed: 1994-01-25
Granted: 1996-08-22
Abstract: The present invention relates to a method and apparatus for abrading a workpiece. The apparatus includes an abrasive tape (22) having a microstructured surface on the back face thereof, and a support shoe (14) having a microstructured surface on an exposed pressure face (18). The two microstructured surfaces intermesh and resist displacement of the abrasive tape with respect to the pressure face as the workpiece is rotatively abraded. <IMAGE>
Patent AU-667248-B2 (AU)
Title: A machine for renewing or cleaning a ballast bed
Inventor: THEURER JOSEF
IPC: E01B27/10
Filed: 1994-01-28
Granted: 1996-03-14
Abstract: A renewal or cleaning apparatus (1) for a ballastway of a track (5) is equipped with an apparatus frame (7) which is supported on the track via rail running gears (6) and on which there are provided, between the rail running gears (6), a ballast-clearing device and a ballast-discharging device (20) arranged after the latter with respect to the working direction of the apparatus (1) and having a discharging end (23). A track-lifting unit (26), capable of rolling along the track (5) via flanged rollers (32), and also a track-tamping unit (27) having a height-adjustable, settable tamping pick (42) and intended for compacting the discharged ballast are arranged, in the working direction, behind the discharging end (23) of the ballast-discharging device (20) and fixed on a common supporting frame (31), and also designed so as to be adjustable together with the latter relative to the apparatus frame (7) in the apparatus longitudinal direction via a drive (39). <IMAGE>
Patent AU-757147-B2 (AU)
Title: Modified human granulocyte-colony stimulating factor and process for producing same
Inventor: KWON SE CHANG
IPC: C12N15/62
Filed: 2000-07-07
Granted: 2003-02-06
Abstract: A modified human granulocyte-colony stimulating factor (hG-CSF) is produced by culturing a microorganism transformed with an expression vector comprising a gene encoding a modified hG-CSF to produce and secrete the modified hG-CSF to periplasm, said modified hG-CSF being obtained by replacing at least one of the 1st, 2nd, 3rd and 17th amino acids of wild-type hG-CSF (SEQ ID NO: 2) with other amino acid.
Patent AU-768816-B2 (AU)
Title: Aminobenzophenones as inhibitors of IL-1beta and TNF-alpha
Inventor: OTTOSEN ERIK RYTTER
IPC: A61P31/04
Filed: 2000-07-11
Granted: 2004-01-08
Abstract: The present invention relates to compounds of formula (I) wherein R1 and R2 independently represent one or more, same or different substituents selected from the group consisting of halogen, hydroxy, mercapto, trifluoromethyl, amino (C1-C3)alkyl, (C2-C3)olefinic group, (C1-C3)alkoxy, (C1-C3)alkylthio, (C1-C6)alkylamino, (C1-C3)alkoxycarbonyl, cyano, carbamoyl, phenyl, or nitro; R2 further being represented by hydrogen; R3 represents hydrogen, halogen, hydroxy, mercapto, trifluoromethyl, amino, (C1-C3)alkyl, (C2-C3)olefinic group, (C1-C3)alkoxy, (C1-C3)alkylthio, (C1-C6)alkylamino, (C1-C3)alkoxycarbonyl, phenyl, cyano, carboxy or carbomoyl; R4 represents hydrogen, (C1-C3)alkyl, or allyl; X represents oxygen or sulpher; with the proviso that formula (I) does not comprise the compound 2,2,2-trifluoro-N-[2-[3-chloro-4-(2-methylbenzoyl)-phenylamino]-phenyl]acetamide wherein R1 is a 2-methyl, R2 is 2-chloro, R3 and R4 is hydrogen, and X is oxygen; and a salt thereof with a pharmaceutically acceptable acid, a hydrate or a solvate thereof. The compounds are valuable in the human and veterinary therapy.
Patent AU-726019-B2 (AU)
Title: System with and method of cryptographically protecting communications
Inventor: JONG EDUARD KAREL DE
IPC: G06Q20/00
Filed: 1996-05-24
Granted: 2000-10-26
Abstract: A value transfer system of at least one VCD (Value Carrying Device) (1) and at least one VAD (Value Accepting Device) (2), the VAD (2) having a memory (53) for storing at least an aggregate value (28) of previous accepted values and a device for transferring a claiming message (13), the VCD (1) having a memory (52) for storing at least a balance value (7) and a device for transferring a proving message (14), wherein the VAD (2) includes into the claiming message (13) a transaction value (20), a previous aggregate value (21) and a corresponding previously computed proving cryptogram (22), the VCD (1) computes and includes into the electronic message (14) a transaction proving cryptogram (35), computed on the basis of the previous aggregate value (21), the corresponding previously computed proving cryptogram (22) and the transaction value (20), and the VCD (1) computes the at least one transaction proving cryptogram (35) only if it has established the correctness of the received previous aggregate value (21) by using the corresponding previously computed cryptogram (22) and after it has reduced the balance value (7) with the transaction value (20).
Patent AU-589978-B2 (AU)
Title: Pyridonecarboxylic acid derivatives
Inventor: HAYAKAWA ISAO
IPC: C07D401/04
Filed: 1986-06-25
Granted: 1989-10-26
Abstract: This invention provides novel pyridonecarboxyic acid derivatives having a quite high antimicrobial activity. The derivatives have the following formula:wherein R<sup>1</sup>, R<sup>2</sup> and R<sup>3</sup> represent each a hydrogen or C<sub>1</sub>-C<sub>8</sub> alkyl group; R<sup>4</sup> represents an ethyl, 2-fluoroethyl, vinyl, isopropyl, isopropenyl or cyclopropyl group; and X represents CH, C-F, C-Cl or N characterized in that R<sup>2</sup> and R<sup>3</sup> are not hydrogen at the same time.
Patent AU-718815-B2 (AU)
Title: Substituted 1-arylpyrazoles
Inventor: STETTER JOERG
IPC: C07D401/04
Filed: 1998-04-03
Granted: 2000-04-20
Abstract: 1-(Phenyl or pyridyl)-4-(trifluoroethylthio, -sulfinyl or -sulfonyl)-pyrazole derivatives (I) are new. Pyrazole derivatives of formula (I) are new. R1 = H, CN, 1-6C alkyl, (1-4C) alkoxy-(1-4C) alkyl, 1-4C haloalkyl or cyano-(1-2C) alkyl; R2 = trifluoroethyl; R3 = H, NH2, halo, -NHCOR4, -N=C(R5)-NR5R6, 1H-pyrrol-1-yl, -N=CR5R6 or -N=C(R5)-OR7; R4 = 1-6C alkyl (optionally substituted by 1-3 halo), (1-6C) alkoxy-(1-6C) alkyl or phenyl (optionally mono-, di- or trisubstituted); R5 = H or 1-6C alkyl; R6 = H, 1-6C alkyl or phenyl (optionally mono-, di- or trisubstituted); or CR5R6 = optionally substituted pyridyl; R7 = 1-6C alkyl; Ar = phenyl or pyridyl (both optionally substituted by 1-3 of halo, 1-6C haloalkyl, 1-6C haloalkylthio, 1-6C haloalkoxy, alkoxy, hydrazino, di-(1-6C alkyl)-hydrazino, NH2, 1-6C mono- or diaminoalkyl, 1-6C iminoalkyl, CN, 1-6C alkylthio or -CONR9R10); R9, R10 = H or alkyl; and n = 0-2. AN Independent claim is also included for the preparation of (I).